EP3958897
MIRIKIZUMAB FOR USE IN A METHOD OF TREATING CROHN'S DISEASE
Status:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á ÍslandiEP appl. date:
15.4.2020EP published:
6.5.2026EP application number:
20724301.5
EPO information:
European Patent Register
Max expiry date:
14.4.2040Expiry date:
14.4.2027
Title in English:
MIRIKIZUMAB FOR USE IN A METHOD OF TREATING CROHN'S DISEASELanguage of the patent:
English
Timeline
Today
15.4.2020EP application
6.5.2026EP Publication
14.4.2027Expires
Owner
Name:
Eli Lilly and CompanyAddress:
Lilly Corporate Center, Indianapolis, IN 46285, US
Inventor
Name:
FRIEDRICH, Stuart WilliamAddress:
Indianapolis, Indiana 46206-6288, US
Name:
POLLACK, Paul FrederickAddress:
Indianapolis, Indiana 46206-6288, US
Name:
TUTTLE, Jay LawrenceAddress:
Indianapolis, Indiana 46206-6288, US
Priority
Number:
201962836910 PDate:
22.4.2019Country:
US
Classification
Categories:
C07K 16/24, A61P 1/00